Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.28 is 34% below its 5-year average of 1.94, near the low end of its 5-year range (1.28–3.42).
As of the fiscal period ended Tuesday, June 30, 2026. 18.70% below its 12-month average of 1.58.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.28.
QUICK RATIO (ACID-TEST)
1.28
QUICK RATIO (ACID-TEST) AVG TTM
1.58
QUICK RATIO (ACID-TEST) AVG 3Y
1.97
QUICK RATIO (ACID-TEST) AVG 5Y
1.94
QUICK RATIO (ACID-TEST) AVG 10Y
1.97
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-18.70%
CURRENT VS 3Y AVG
-34.90%
CURRENT VS 5Y AVG
-33.72%
CURRENT VS 10Y AVG
-34.90%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
-58.22%
vs the sector median at left
Market Cap
$490.16M
Quick Ratio (Acid-Test)
2.64
TTM Avg
1.69
3Y Avg
1.64
5Y Avg
1.50
Market Cap
$483.04M
Quick Ratio (Acid-Test)
7.91
TTM Avg
4.78
3Y Avg
4.69
5Y Avg
6.49
Market Cap
$500.37M
Quick Ratio (Acid-Test)
8.35
TTM Avg
4.17
3Y Avg
3.90
5Y Avg
4.80
Market Cap
$479.85M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$475.46M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$473.85M
Quick Ratio (Acid-Test)
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$510.83M
Quick Ratio (Acid-Test)
10.72
TTM Avg
8.23
3Y Avg
9.67
5Y Avg
9.58
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $491.28M | 1.28 | 1.58 | 1.97 | 1.94 |
| Puma Biotechnology, Inc. (PBYI)vs › | $490.16M | 2.64 | 1.69 | 1.64 | 1.50 |
| Arvinas, Inc. (ARVN)vs › | $483.04M | 7.91 | 4.78 | 4.69 | 6.49 |
| Oculis Holding AG (OCS)vs › | $500.37M | 8.35 | 4.17 | 3.90 | 4.80 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $479.85M | 121.97 | 23.71 | 19.95 | 19.50 |
| Cerus Corporation (CERS)vs › | $475.46M | 1.07 | 1.48 | 1.43 | 1.74 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.85M | 37.17 | 24.09 | 19.47 | 19.38 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $510.83M | 10.72 | 8.23 | 9.67 | 9.58 |
| Kamada Ltd. (KMDA)vs › | $468.48M | 2.29 | 2.21 | 1.73 | 2.24 |
| 908 Devices Inc. (MASS)vs › | $514.28M | 2.38 | 3.66 | 6.23 | 9.46 |
Quick Ratio
1.28
Excludes inventory
Current Ratio
1.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.28 |
| 2026-03-31 | 1.68 |
| 2025-12-31 | 1.54 |
| 2025-09-30 | 1.53 |
| 2025-06-30 | 1.86 |
| 2025-03-31 | 2.16 |
| 2024-12-31 | 2.21 |
| 2024-09-30 | 2.23 |
| 2024-06-30 | 2.67 |
| 2024-03-31 | 2.96 |
| 2023-12-31 | 2.10 |
| 2023-09-30 | 1.53 |
| 2023-06-30 | 1.85 |
| 2023-03-31 | 1.49 |
| 2022-12-31 | 1.76 |
| 2022-09-30 | 1.84 |
| 2022-06-30 | 2.36 |
| 2022-03-31 | 3.42 |
| 2021-12-31 | 3.07 |
| 2021-09-30 | 1.89 |
| 2021-06-30 | 1.82 |
| 2021-03-31 | 0.86 |
| 2020-12-31 | 0.69 |
| 2020-09-30 | 10.03 |
| 2020-06-30 | 5.02 |
| 2020-03-31 | 5.02 |
| 2019-12-31 | 5.97 |
| 2019-09-30 | 3.28 |
| 2019-06-30 | 4.51 |
| 2019-03-31 | 14.52 |
| 2018-12-31 | 17.88 |
| 2018-09-30 | 19.43 |
| 2018-06-30 | 12.11 |
| 2018-03-31 | 13.81 |
| 2017-12-31 | 0.34 |
| 2017-09-30 | 0.01 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
